• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pancastatin A 和 B 对葡萄糖剥夺的 PANC-1 人胰腺癌细胞具有选择性细胞毒性。

Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells.

机构信息

School of Bioconvergence, Kyungnam University, Changwon 51767, Republic of Korea.

出版信息

J Microbiol Biotechnol. 2020 May 28;30(5):733-738. doi: 10.4014/jmb.2002.02002.

DOI:10.4014/jmb.2002.02002
PMID:32482939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9728248/
Abstract

Glucose deprivation and hypoxia frequently occur in solid tumor cells, including pancreatic cancer cells. Glucose deprivation activates the unfolded protein response (UPR) and causes the upregulation of glucose-regulated protein 78 (GRP78). Induction of GRP78 has been shown to protect cancer cells. Therefore, shutting down of GRP78 expression may be a novel strategy in anticancer drug development. Based on this understanding, a screening system established for anticancer agents that exhibit selective cytotoxicity on pancreatic cancer cells under glucose-deprived conditions. To test this hypothesis, the new compounds isolated, pancastatin A (PST-A) and B (PSTB), from Ponciri Fructus. PST-A and B were identified as glabretal triterpenoid moieties by electrospray ionization mass spectrometry and nuclear magnetic resonance spectroscopic methods. PST-A and B suppressed the accumulation of the UPR hallmark gene, GRP78, during glucose deprivation. Furthermore, PST-A and B showed selective cytotoxicity on PANC-1 pancreatic cancer cells under glucose deprivation. Interestingly, PST-A and B had no effect on these cells under normal growth conditions. Our results suggest that PST-A and B act as novel therapeutic agents to induce selective cell death in glucose-deprived pancreatic cancer cells.

摘要

葡萄糖剥夺和缺氧经常发生在实体肿瘤细胞中,包括胰腺癌细胞。葡萄糖剥夺会激活未折叠蛋白反应 (UPR),并导致葡萄糖调节蛋白 78 (GRP78) 的上调。已证明诱导 GRP78 的表达可以保护癌细胞。因此,关闭 GRP78 的表达可能是抗癌药物开发的一种新策略。基于这一理解,建立了一种筛选系统,用于筛选在葡萄糖剥夺条件下对胰腺癌细胞具有选择性细胞毒性的抗癌药物。为了验证这一假说,从枳椇果实中分离得到的新化合物,蓬砂 A (PST-A) 和蓬砂 B (PSTB)。通过电喷雾电离质谱和核磁共振波谱方法鉴定 PST-A 和 B 为 glabretal 三萜类部分。PST-A 和 B 在葡萄糖剥夺时抑制 UPR 特征基因 GRP78 的积累。此外,PST-A 和 B 在葡萄糖剥夺下对 PANC-1 胰腺癌细胞表现出选择性细胞毒性。有趣的是,PST-A 和 B 在正常生长条件下对这些细胞没有影响。我们的结果表明,PST-A 和 B 可作为诱导葡萄糖剥夺的胰腺癌细胞选择性细胞死亡的新型治疗剂。

相似文献

1
Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells.Pancastatin A 和 B 对葡萄糖剥夺的 PANC-1 人胰腺癌细胞具有选择性细胞毒性。
J Microbiol Biotechnol. 2020 May 28;30(5):733-738. doi: 10.4014/jmb.2002.02002.
2
Selective cytotoxicity of Ponciri Fructus against glucose-deprived PANC-1 human pancreatic cancer cells via blocking activation of GRP78.枳壳果实通过阻断葡萄糖调节蛋白78(GRP78)的激活对葡萄糖剥夺的人胰腺癌细胞PANC-1具有选择性细胞毒性。
Biosci Biotechnol Biochem. 2009 Oct;73(10):2167-71. doi: 10.1271/bbb.90235. Epub 2009 Oct 7.
3
Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator.葡萄糖剥夺的HT-29人结肠癌细胞对作为GRP78下调剂的疣孢菌素敏感。
Toxicology. 2007 Jan 18;229(3):253-61. doi: 10.1016/j.tox.2006.11.049. Epub 2006 Nov 17.
4
HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.HHQ-4,一种喹啉衍生物,作为一种 GRP78 下调剂,优先抑制葡萄糖剥夺的乳腺癌细胞的增殖。
Toxicol Appl Pharmacol. 2019 Jun 15;373:10-25. doi: 10.1016/j.taap.2019.04.017. Epub 2019 Apr 22.
5
A Triterpene Lactone from Callistemon citrinus Inhibits the PANC-1 Human Pancreatic Cancer Cells Viability through Suppression of Unfolded Protein Response.从变色桉中提取的三萜内酯通过抑制未折叠蛋白反应抑制人胰腺癌细胞 PANC-1 的活力。
Chem Biodivers. 2020 Oct;17(10):e2000495. doi: 10.1002/cbdv.202000495. Epub 2020 Sep 30.
6
The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer.羟喹啉类似物 YUM70 通过抑制 GRP78 诱导胰腺癌内质网应激介导的细胞凋亡。
Cancer Res. 2021 Apr 1;81(7):1883-1895. doi: 10.1158/0008-5472.CAN-20-1540. Epub 2021 Feb 2.
7
CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.CLPTM1L/CRR9 细胞表面与 GRP78 的外显域相互作用,在胰腺腺癌细胞内质网应激时发出存活和化疗耐药信号。
Int J Cancer. 2019 Mar 15;144(6):1367-1378. doi: 10.1002/ijc.32012. Epub 2019 Jan 3.
8
Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.双去甲氧基姜黄素通过线粒体功能障碍和GRP78依赖途径在人胰腺腺癌细胞中发挥促凋亡作用。
Oncotarget. 2016 Dec 13;7(50):83641-83656. doi: 10.18632/oncotarget.13272.
9
New Glabretal Triterpenes from the Immature Fruits of Poncirus trifoliata and Their Selective Cytotoxicity.从枳椇未成熟果实中分离得到的新型三萜类化合物及其选择性细胞毒性
Chem Pharm Bull (Tokyo). 2015;63(12):1065-9. doi: 10.1248/cpb.c15-00465.
10
Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.桦木酸通过直接靶向 GRP78 触发内质网应激介导的细胞凋亡使乳腺癌细胞对化疗药物敏感。
Cell Death Dis. 2018 May 25;9(6):636. doi: 10.1038/s41419-018-0669-8.

引用本文的文献

1
Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy.解析非编码 RNA 在胰腺癌免疫逃逸和耐药中的作用:靶向治疗的新视角。
Front Immunol. 2024 Nov 1;15:1480572. doi: 10.3389/fimmu.2024.1480572. eCollection 2024.
2
Bioactive Chemical Constituents and Pharmacological Activities of Ponciri Fructus.枳实的生物活性化学成分及药理活性。
Molecules. 2022 Dec 28;28(1):255. doi: 10.3390/molecules28010255.
3
Anti-Obesity Potential of Ponciri Fructus: Effects of Extracts, Fractions and Compounds on Adipogenesis in 3T3-L1 Preadipocytes.

本文引用的文献

1
New Glabretal Triterpenes from the Immature Fruits of Poncirus trifoliata and Their Selective Cytotoxicity.从枳椇未成熟果实中分离得到的新型三萜类化合物及其选择性细胞毒性
Chem Pharm Bull (Tokyo). 2015;63(12):1065-9. doi: 10.1248/cpb.c15-00465.
2
The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.胰十二指肠切除术治疗胰导管腺癌后的延长重症监护需求。
Langenbecks Arch Surg. 2011 Mar;396(3):353-62. doi: 10.1007/s00423-010-0629-y. Epub 2010 Mar 25.
3
Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?
化橘红的抗肥胖潜力:提取物、馏分和化合物对 3T3-L1 前体脂肪细胞脂肪生成的影响。
Molecules. 2022 Jan 20;27(3):676. doi: 10.3390/molecules27030676.
4
Modulation of cell physiology under hypoxia in pancreatic cancer.缺氧条件下胰腺癌细胞生理学的调控。
World J Gastroenterol. 2021 Jul 28;27(28):4582-4602. doi: 10.3748/wjg.v27.i28.4582.
改善可切除胰腺癌的治疗效果:能否进行更安全的手术是问题所在吗?
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1036-45. doi: 10.1111/j.1440-1746.2008.05471.x.
4
GRP78 induction in cancer: therapeutic and prognostic implications.癌症中GRP78的诱导:治疗和预后意义
Cancer Res. 2007 Apr 15;67(8):3496-9. doi: 10.1158/0008-5472.CAN-07-0325.
5
Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator.葡萄糖剥夺的HT-29人结肠癌细胞对作为GRP78下调剂的疣孢菌素敏感。
Toxicology. 2007 Jan 18;229(3):253-61. doi: 10.1016/j.tox.2006.11.049. Epub 2006 Nov 17.
6
Glucose regulated proteins in cancer progression, drug resistance and immunotherapy.癌症进展、耐药性及免疫治疗中的葡萄糖调节蛋白
Cancer Biol Ther. 2006 Jul;5(7):741-4. doi: 10.4161/cbt.5.7.2970. Epub 2006 Jul 1.
7
RETRACTED: Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha.撤回:促凋亡蛋白BAX和BAK通过与IRE1α直接相互作用调节未折叠蛋白反应。
Science. 2006 Apr 28;312(5773):572-6. doi: 10.1126/science.1123480.
8
Researchers target unfolded protein response in cancerous tumor growth.研究人员将癌性肿瘤生长中的未折叠蛋白反应作为靶点。
J Natl Cancer Inst. 2006 Apr 19;98(8):512-4. doi: 10.1093/jnci/djj174.
9
Stress induction of GRP78/BiP and its role in cancer.GRP78/BiP的应激诱导及其在癌症中的作用。
Curr Mol Med. 2006 Feb;6(1):45-54. doi: 10.2174/156652406775574523.
10
Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation.牛蒡子苷元作为一种具有消除癌细胞对营养饥饿耐受性能力的抗肿瘤剂的鉴定。
Cancer Res. 2006 Feb 1;66(3):1751-7. doi: 10.1158/0008-5472.CAN-05-3143.